Virtual Reality and Neurostimulation for Early Stroke Rehabilitation
Stroke is one of the leading causes of disability, leaving millions of individuals each year impaired with lasting motor and sensory impairments. In the subacute phase, which goes from the first week to 3 months post-stroke, the patient has the highest recovery, which could be boosted by proper technologies intended fo
| Condition(s) | Stroke |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Stroke is one of the leading causes of disability, leaving millions of individuals each year impaired with lasting motor and sensory impairments. In the subacute phase, which goes from the first week to 3 months post-stroke, the patient has the highest recovery, which could be boosted by proper technologies intended for the rehabilitation of the patients. The impairments that the patients experience are extremely heterogeneous and go from muscle weakness to spasticity of the paretic side of the body. Beyond motor deficits, stroke survivors also suffer from sensory impairment (they do not properly feel with the paretic side of their body), impaired body representation (misjudging the size, position, and movement of their affected limb), which can further hinder recovery. Traditional rehabil |
| Who can participate | Inclusion Criteria: * Confirmed diagnosis of ischemic or hemorrhagic stroke * In the subacute phase (from 7 days to 3 months from last stroke onset) * Fugl-Meyer-Upper Extremity (FMUE) scale for the motor part: FMUE ≥ 10 * Ability to sit in an upright position * Age between 18 and 80 years Exclusion Criteria: * Other neurological or physical impairment or mental condition that, in the judgment of the investigator, does not allow participation in the study. * Mini-Mental State Examination (MMSE) \< 24 * Epilepsy * Nausea, headaches or fatigue due to VR-generated environment ("virtual reality motion sickness") * Peripheral nerve damage in the affected arm or hand * Pacemaker or other electronic implants |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Lead sponsor | Medical University of Vienna |
| Locations | Vienna, State of Vienna, Austria |
| Start date | 2025-03-17 |
| NCT ID | NCT06887231 |
| Official listing | https://clinicaltrials.gov/study/NCT06887231 |